HOME >> BIOLOGY >> NEWS
Flexible electronics could find applications as sensors, artificial muscles

Flexible electronic structures with the potential to bend, expand and manipulate electronic devices are being developed by researchers at the U.S. Department of Energy's Argonne National Laboratory and the University of Illinois at Urbana-Champaign. These flexible structures could find useful applications as sensors and as electronic devices that can be integrated into artificial muscles or biological tissues.

In addition to a biomedical impact, flexible electronics are important for energy technology as flexible and accurate sensors for hydrogen.

These structures were developed from a concept created by Argonne scientist Yugang Sun and a team of researchers at the University of Illinois led by John A. Rogers. The concept focuses on forming single-crystalline semiconductor nanoribbons in stretchable geometrical configurations with emphasis on the materials and surface chemistries used in their fabrication and the mechanics of their response to applied strains.

"Flexible electronics are typically characterized by conducting plastic-based liquids that can be printed onto thin, bendable surfaces," Sun said. "The objective of our work was to generate a concept along with subsequent technology that would allow for electronic wires and circuits to stretch like rubber bands and accordions leading to sensor-embedded covers for aircraft and robots, and even prosthetic skin for humans.

"We are presently developing stretchable electronics and sensors for smart surgical gloves and hemispherical electronic eye imagers," he added.

The team of researchers has been successful in fabricating thin ribbons of silicon and designing them to bend, stretch and compress like an accordion without losing their ability to function. The detailed results of these findings were published in the Journal of Materials Chemistry paper, " Structural forms of single crystal semiconductor nanoribbons for high-performance stretchable electronics," whi
'"/>

Contact: Sylvia Carson
scarson@anl.gov
630-252-5510
DOE/Argonne National Laboratory
2-Apr-2007


Page: 1 2

Related biology news :

1. Flexible genes allow ants to change destiny
2. Deflecting damage: Flexible electronics aid brain injury research
3. Juiced-up battery fueled by sugar could power small portable electronics
4. Solitons could power molecular electronics, artificial muscles
5. New U. of Colorado polymer has applications for dentistry, electronics, automobiles
6. Successful test of single molecule switch opens the door to biomolecular electronics
7. MIT: Recycling of scrapped electronics studied
8. Newly created cancer stem cells could aid breast cancer research
9. New system of wastewater treatment could reduce the size of treatment plants by half
10. Discovery of new protein could provide new understanding of male fertility
11. Einstein researchers prototype vaccine could provide improved protection against tuberculosis

Post Your Comments:
(Date:5/19/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
(Date:5/21/2015)... , May 21, 2015  The EveryLife ... Hatch (R-UT) and Amy Klobuchar ... Now Accelerating Cures & Treatments, or OPEN ACT. ... disease patient advocacy organizations, this bipartisan legislation promises ... affordable medicines to rare disease patients by incentivizing ...
(Date:5/21/2015)... May 21, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced positive updated results ... aldoxorubicin for the treatment of unresectable glioblastoma multiforme ... open-label, multisite trial is designed to investigate the ... whose tumors have progressed following prior treatment with ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Veolia’s ... an exclusive North American distribution agreement with VWR ... system. , With more than 160 years of ... and services for laboratory and production facilities, has ... excellence and differentiated services to enable science. ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 This year ... especially for lawns. US Patented Pearl’s Premium Ultra ... lawns around the country that are coming out of ... addresses a number of major global concerns related to ... “non-grass” grass – the alternative to the standard, water-wasting, ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2
Cached News: